Calquence 100 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FZ0GW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,188
Award facts
- Contract value 100% obligated
- $11,187.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Calquence 100 mg tablets (60-count units) with a contract value of $11,187.56. This firm fixed-price delivery order, with an ultimate completion date of September 23, 2025, represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Calquence is a prescription medication used in the treatment of certain blood cancers and immune disorders, reflecting the Defense Logistics Agency's ongoing procurement of specialized pharmaceutical products for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime contract vehicle valued through December 2026 that provides comprehensive global pharmaceutical support to military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and maintains an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's current role within the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program reflects its capability to meet federal procurement requirements through competitive procurement processes.
Quick answers
Who was awarded contract SPE2DB25FZ0GW?
SPE2DB25FZ0GW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FZ0GW worth?
The government has obligated $11,188 on SPE2DB25FZ0GW.
Is contract SPE2DB25FZ0GW an order under another contract?
Yes. SPE2DB25FZ0GW is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FZ0GW competed?
The extent of competition for SPE2DB25FZ0GW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award